Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.
2.

Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.

Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.

Acta Haematol. 2009;121(2-3):119-27. doi: 10.1159/000214852. Epub 2009 Jun 8. Review.

PMID:
19506358
3.

Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene.

Hilbert L, Jorieux S, Fontenay-Roupie M, Guicheteau M, Fressinaud E, Meyer D, Mazurier C; INSERM Network on Molecular Abnormalities in von Willebrand Disease..

Br J Haematol. 2004 Oct;127(2):184-9. Review.

PMID:
15461624
4.

Laboratory diagnosis and molecular classification of von Willebrand disease.

Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.

Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8. Review.

PMID:
19506352
6.

Molecular genetics of type 2 von Willebrand disease.

Fressinaud E, Mazurier C, Meyer D.

Int J Hematol. 2002 Jan;75(1):9-18. Review.

PMID:
11843298
8.

Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.

Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H.

Semin Thromb Hemost. 2005 Nov;31(5):577-601. Review.

PMID:
16276467
9.

Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.

Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.

Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. Review.

PMID:
16959681
10.

Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.

Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ.

Acta Haematol. 2009;121(2-3):145-53. doi: 10.1159/000214855. Epub 2009 Jun 8. Review.

PMID:
19506361
11.

Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.

Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van Vliet HH.

Acta Haematol. 2009;121(2-3):85-97. doi: 10.1159/000214847. Epub 2009 Jun 8. Review.

PMID:
19506353
12.

Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation.

Wise RJ, Ewenstein BM, Gorlin J, Narins SC, Jesson M, Handin RI.

Hum Genet. 1993 May;91(4):367-72. Review.

PMID:
8500791
13.

Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.

Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.

Clin Appl Thromb Hemost. 2006 Oct;12(4):397-420. Review.

PMID:
17000885
14.

Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.

Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.

Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. Review.

PMID:
17164493
15.

Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM Network on Molecular Abnormalities in von Willebrand Disease.

Meyer D, Fressinaud E, Gaucher C, Lavergne JM, Hilbert L, Ribba AS, Jorieux S, Mazurier C.

Thromb Haemost. 1997 Jul;78(1):451-6. Review.

PMID:
9198195
16.

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.

Michiels JJ, van Vliet HH, Berneman Z, Schroyens W, Gadisseur A.

Acta Haematol. 2009;121(2-3):167-76. doi: 10.1159/000214857. Epub 2009 Jun 8. Review.

PMID:
19506363
17.

Molecular mechanism and classification of von Willebrand disease.

Sadler JE, Matsushita T, Dong Z, Tuley EA, Westfield LA.

Thromb Haemost. 1995 Jul;74(1):161-6. Review.

PMID:
8578450
18.

Von Willebrand disease - phenotype versus genotype: deficiency versus disease.

Lillicrap D.

Thromb Res. 2007;120 Suppl 1:S11-6. Epub 2007 May 8. Review.

PMID:
17490730
19.

Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains.

Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, Berneman Z.

Acta Haematol. 2009;121(2-3):111-8. doi: 10.1159/000214851. Epub 2009 Jun 8. Review.

PMID:
19506357
20.

The factor VIII/von Willebrand factor complex: basic and clinical issues.

Federici AB.

Haematologica. 2003 Jun;88(6):EREP02. Review.

PMID:
12826528

Supplemental Content

Support Center